J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Linezolid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

85 API Suppliers, 30 USDMF, 5 JDMF, 19 EU WC, 7 KDMF, 19 NDC API, 52 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

190 FDF Dossiers, 36 FDA Orange Book, 62 Europe, 7 Canada, 22 South Africa, 63 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML), SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 18 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 9 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 30 BASF, 2 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 8 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

93 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 49 Disintegrants & Superdisintegrants, 39 Direct Compression, 37 Thickeners and Stabilizers, 34 Granulation, 33 Controlled & Modified Release, 27 Taste Masking, 22 Lubricants & Glidants, 20 Solubilizers, 20 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 17 Film Formers & Plasticizers, 15 Parenteral, 14 Topical, 12 Rheology Modifiers, 5 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Emulsifying Agents, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 44 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 40 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

47 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

9 Others

9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/06/2025	Alivus Life Sciences	India	Alives Life Sciences Limited	229MF10166	Linezolid	2017-08-22	2018-05-21	4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India
28/06/2025	Formosa Laboratories	Taiwan	FORMOSA LABORATORIES, INC.	226MF10166	Linezolid for oral use	2014-09-01	2014-11-17	36 Hoping Street, Louchu, Taoyuan 33842, Taiwan

Linezolid

Linezolid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

85 API Suppliers

30 USDMF

5 JDMF

19 EU WC

7 KDMF

19 NDC API

52 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

190 FDF Dossiers

36 FDA Orange Book

62 Europe

7 Canada

22 South Africa

63 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 600MG

SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML)

SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem

4 Rochem International Inc

18 SPI Pharma

9 DKSH

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

9 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 ACG Worldwide

9 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

30 BASF

2 Clariant

12 Corel Pharma Chem

6 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

1 Finar

8 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

4 Ideal Cures

5 Ingredion Pharma Solutions

31 Kerry

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

25 Roquette

7 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

4 The Dow Chemical Company

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons